Drug information for DIMENHYDRINATE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 50MG/ML Prescription AP  DIMENHYDRINATE Dimenhydrinate APP PHARMS 40519
INJECTABLE; INJECTION 50MG/ML Prescription AP (Reference Drug) DIMENHYDRINATE Dimenhydrinate WATSON LABS 80615
INJECTABLE; INJECTION 50MG/ML Discontinued   DIMENHYDRINATE Dimenhydrinate WATSON LABS 83531
INJECTABLE; INJECTION 50MG/ML Discontinued   DIMENHYDRINATE Dimenhydrinate WYETH AYERST 84316
INJECTABLE; INJECTION 50MG/ML Discontinued   DIMENHYDRINATE Dimenhydrinate BAXTER HLTHCARE 84767
LIQUID; ORAL 12.5MG/4ML Discontinued   DIMENHYDRINATE Dimenhydrinate ALRA 80715
TABLET; ORAL 50MG Discontinued   DIMENHYDRINATE Dimenhydrinate HEATHER 80841
TABLET; ORAL 50MG Discontinued   DIMENHYDRINATE Dimenhydrinate WATSON LABS 85166
TABLET; ORAL 50MG Discontinued   DIMENHYDRINATE Dimenhydrinate NEXGEN PHARMA INC 85985

Drug Adverse Effects information for DIMENHYDRINATE

Role code Indications Reaction # Reports
SS FOETAL EXPOSURE DURING PREGNANCY GASTROSCHISIS 4
C BLOOD PRESSURE SYSTOLIC ASTHENIA 1
C BLOOD PRESSURE SYSTOLIC DECREASED APPETITE 1
C BLOOD PRESSURE SYSTOLIC NEOPLASM MALIGNANT 1
C BLOOD PRESSURE SYSTOLIC NEOPLASM PROGRESSION 1
C BLOOD PRESSURE SYSTOLIC RENAL FAILURE 1
C BREAST CANCER METASTATIC DEHYDRATION 2
C BREAST CANCER METASTATIC HYPERGLYCAEMIA 2
C BREAST CANCER METASTATIC HYPOKALAEMIA 2
C BREAST CANCER METASTATIC METABOLIC ALKALOSIS 2
C BREAST CANCER METASTATIC NEUTROPENIA 2
C BREAST CANCER METASTATIC PLATELET COUNT DECREASED 2
C BREAST CANCER METASTATIC SEPTIC SHOCK 2
C CARCINOID TUMOUR ASTHENIA 2
C CARCINOID TUMOUR DECREASED APPETITE 2
C CARCINOID TUMOUR NEOPLASM MALIGNANT 2
C CARCINOID TUMOUR NEOPLASM PROGRESSION 2
C CARCINOID TUMOUR RENAL FAILURE 2
C CHEMOTHERAPY MULTIPLE AGENTS SYSTEMIC ASTHENIA 1
C CHEMOTHERAPY MULTIPLE AGENTS SYSTEMIC DECREASED APPETITE 1
C CHEMOTHERAPY MULTIPLE AGENTS SYSTEMIC NEOPLASM MALIGNANT 1
C CHEMOTHERAPY MULTIPLE AGENTS SYSTEMIC NEOPLASM PROGRESSION 1
C CHEMOTHERAPY MULTIPLE AGENTS SYSTEMIC RENAL FAILURE 1
C CROHN'S DISEASE DECREASED APPETITE 1
C CROHN'S DISEASE DIARRHOEA 1
C CROHN'S DISEASE FEELING ABNORMAL 1
C CROHN'S DISEASE HERPES ZOSTER 1
C CROHN'S DISEASE HYPERSENSITIVITY 1
C CROHN'S DISEASE INTESTINAL MASS 1
C CROHN'S DISEASE LOCALISED INFECTION 1
C CROHN'S DISEASE SYNCOPE 1
C CROHN'S DISEASE VOMITING 1
C CROHN'S DISEASE WEIGHT DECREASED 1
C DEPRESSION CAESAREAN SECTION 1
C DEPRESSION MATERNAL EXPOSURE DURING PREGNANCY 1
C MULTIPLE MYELOMA DEATH 1
C MULTIPLE MYELOMA HEPATIC NEOPLASM MALIGNANT 2
C MUSCLE RELAXANT THERAPY DECREASED APPETITE 1
C MUSCLE RELAXANT THERAPY DIARRHOEA 1
C MUSCLE RELAXANT THERAPY FEELING ABNORMAL 1
C MUSCLE RELAXANT THERAPY HERPES ZOSTER 1
C MUSCLE RELAXANT THERAPY HYPERSENSITIVITY 1
C MUSCLE RELAXANT THERAPY INTESTINAL MASS 1
C MUSCLE RELAXANT THERAPY LOCALISED INFECTION 1
C MUSCLE RELAXANT THERAPY SYNCOPE 1
C MUSCLE RELAXANT THERAPY VOMITING 1
C MUSCLE RELAXANT THERAPY WEIGHT DECREASED 1
C NAUSEA ASTHENIA 1
C NAUSEA DECREASED APPETITE 1
C NAUSEA HEPATIC NEOPLASM MALIGNANT 1
C NAUSEA NEOPLASM MALIGNANT 1
C NAUSEA NEOPLASM PROGRESSION 1
C NAUSEA RENAL FAILURE 1
C NEOPLASM MALIGNANT ILEUS 2
C NEOPLASM MALIGNANT NAUSEA 2
C NEOPLASM MALIGNANT PNEUMONIA ASPIRATION 2
C NEOPLASM MALIGNANT VOMITING 2
C NEURALGIA APALLIC SYNDROME 2
C NEURALGIA ASTHENIA 2
C NEURALGIA BURNING FEET SYNDROME 2
C NEURALGIA CONDITION AGGRAVATED 2
C NEURALGIA DIZZINESS 2
C NEURALGIA HYPERHIDROSIS 2
C NEURALGIA NAUSEA 2
C NEURALGIA PAIN 2
C NEURALGIA RADICULOPATHY 2
C NEURALGIA RESTLESSNESS 2
C NEURALGIA VOMITING 2
C PAIN DECREASED APPETITE 2
C PAIN DIARRHOEA 2
C PAIN FEELING ABNORMAL 2
C PAIN HEPATIC NEOPLASM MALIGNANT 2
C PAIN HERPES ZOSTER 2
C PAIN HYPERSENSITIVITY 2
C PAIN INTESTINAL MASS 2
C PAIN LOCALISED INFECTION 2
C PAIN SYNCOPE 2
C PAIN VOMITING 2
C PAIN WEIGHT DECREASED 2
C PRODUCT USED FOR UNKNOWN INDICATION ATRIAL SEPTAL DEFECT 1
C PRODUCT USED FOR UNKNOWN INDICATION DECREASED APPETITE 1
C PRODUCT USED FOR UNKNOWN INDICATION DIARRHOEA 1
C PRODUCT USED FOR UNKNOWN INDICATION DRUG WITHDRAWAL SYNDROME NEONATAL 1
C PRODUCT USED FOR UNKNOWN INDICATION FEELING ABNORMAL 1
C PRODUCT USED FOR UNKNOWN INDICATION HAEMANGIOMA CONGENITAL 1
C PRODUCT USED FOR UNKNOWN INDICATION HERPES ZOSTER 1
C PRODUCT USED FOR UNKNOWN INDICATION HYPERSENSITIVITY 1
C PRODUCT USED FOR UNKNOWN INDICATION INTESTINAL MASS 1
C PRODUCT USED FOR UNKNOWN INDICATION LARGE FOR DATES BABY 1
C PRODUCT USED FOR UNKNOWN INDICATION LOCALISED INFECTION 1
C PRODUCT USED FOR UNKNOWN INDICATION MATERNAL DRUGS AFFECTING FOETUS 1
C PRODUCT USED FOR UNKNOWN INDICATION NEONATAL RESPIRATORY DISTRESS SYNDROME 1
C PRODUCT USED FOR UNKNOWN INDICATION PETECHIAE 1
C PRODUCT USED FOR UNKNOWN INDICATION RESPIRATORY FAILURE 1
C PRODUCT USED FOR UNKNOWN INDICATION SYNCOPE 1
C PRODUCT USED FOR UNKNOWN INDICATION TRANSAMINASES INCREASED 1
C PRODUCT USED FOR UNKNOWN INDICATION VOMITING 1
C PRODUCT USED FOR UNKNOWN INDICATION WEIGHT DECREASED 1
C PROPHYLAXIS HEPATIC NEOPLASM MALIGNANT 9
C SLEEP DISORDER THERAPY DECREASED APPETITE 1
C SLEEP DISORDER THERAPY DIARRHOEA 1
C SLEEP DISORDER THERAPY FEELING ABNORMAL 1
C SLEEP DISORDER THERAPY HERPES ZOSTER 1
C SLEEP DISORDER THERAPY HYPERSENSITIVITY 1
C SLEEP DISORDER THERAPY INTESTINAL MASS 1
C SLEEP DISORDER THERAPY LOCALISED INFECTION 1
C SLEEP DISORDER THERAPY SYNCOPE 1
C SLEEP DISORDER THERAPY VOMITING 1
C SLEEP DISORDER THERAPY WEIGHT DECREASED 1
C SUPPLEMENTATION THERAPY HEPATIC NEOPLASM MALIGNANT 3
C UPPER RESPIRATORY TRACT INFECTION HEPATIC NEOPLASM MALIGNANT 2
C VITAMIN B12 DEFICIENCY HEPATIC NEOPLASM MALIGNANT 1
I PRODUCT USED FOR UNKNOWN INDICATION DRUG INTERACTION 6
I PRODUCT USED FOR UNKNOWN INDICATION VENTRICULAR TACHYCARDIA 6
Ads by Google